Top Markets
Coin of the day
Lepu Biopharma Co., Ltd. Lepu Biopharma Co., Ltd.

Lepu Biopharma Co., Ltd.

2157
Rangering i aksjer #9736
Lepu Biopharma Co., Ltd. operates as a biopharmaceutical enterprise,... Lepu Biopharma Co., Ltd. operates as a biopharmaceutical enterprise, concentrating its efforts on the development of innovative oncology therapies. It maintains a broad pipeline of cancer-fighting products primarily aimed at the Chinese market. The company's therapeutic candidates encompass a range of modalities, including cutting-edge antibody-drug conjugates (ADCs), oncolytic virus treatments, and diverse immunotherapies. Among its immuno-oncology offerings are HX008 (an anti-PD-1 mAb) and LP002 (an anti-PD-L1 mAb). The ADC portfolio features MRG003 (targeting EGFR), MRG002 (targeting HER2), MRG001 (targeting CD20), MRG004A (targeting TF), and CMG901 (targeting CLDN18.2). Additionally, Lepu Biopharma is advancing the oncolytic virus CG0070, along with various combination therapies such as HX008+OH2, LP002+OH2, and HX008+LP002. Founded in 2018, the company is headquartered in Shanghai, China.
Aksjekurs
$0.53025422
Sist synkronisert: 2026-08-28
Markedsverdi
$956.81M
Endring (1 dag)
0.61%
Endring (1 år)
-52.36%
Land
CN
Handel Lepu Biopharma Co., Ltd. (2157)

Kategori

Historikk for aksjesplitt for Lepu Biopharma Co., Ltd. (2157)
Aksjen Lepu Biopharma Co., Ltd. (symbol: 2157) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 29, 2026.
Én 2157-aksje kjøpt før Aug 29, 2026 tilsvarer i dag 0 2157-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH